Find disease awareness content and relevant supporting materials

The PRIME trial provides evidence for biparametric MRI as a new standard-of-care alternative to multiparametric MRI in prostate cancer diagnosis.

The European Thyroid Association (ETA) guidelines provide detailed recommendations for cervical ultrasound scanning and ultrasound-guided techniques in the postoperative management of thyroid cancer patients. These guidelines aim to standardize procedures, improve diagnostic accuracy, and optimize patient outcomes.

Objective: To evaluate whether total serum PSA, free-PSA ratio and PSA density have similar diagnostic properties for detecting prostate cancer (PCa) and clinically-significant (cs) PCa in men with normal testosterone compared...

Since its introduction in the diagnostic pathway of prostate cancer management, prostate-specific membrane antigen (PSMA)-ligand positron-emission tomography (PET) has demonstrated great potential.

A small Phase I trial of an MRI-guided focal laser ablation system, from Visualase, designed to treat the diseased portion...

To investigate gut bacterial diversity, identify specific metabolic pathways associated with disease, and develop a microbiome risk profile for prostate cancer.

-Hologic, Inc. announced the U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the Company’s suite of ultrasound technologies with its first premium, cart-based system.

The American Society of Clinical Oncology (ASCO) has updated its guideline on sentinel lymph node biopsy (SLNB) for early-stage breast cancer. These recommendations refine the use of SLNB and axillary lymph node dissection (ALND) based on patient characteristics, tumor biology, and surgical approach.

Insightec announced that The National Institute for Health and Care Excellence (NICE) issued a positive NICE guidance for unilateral MRI-guided...

MDNA Life Sciences announces that its breakthrough Mitomic Prostate Test (MPT) � the world�s most accurate blood test to determine...